A patient will be taking dabigatran (Pradaxa) as part of treatment for chronic atrial fibrillation. Which statements about dabigatran are true?
A) The dose of dabigatran is reduced in patients with decreased renal function.
B) Bleeding is the most common adverse effect.
C) Idarucizumab (Praxbind) is given as an antidote in cases of uncontrolled bleeding.
D) Dabigatran levels are monitored by measuring prothrombin time/international normalized ratio (PT/INR) results.
E) This drug is a prodrug and becomes activated in the liver.
Correct Answer:
Verified
Q1: The nurse is reviewing new medication orders
Q2: An elderly patient has had hip surgery
Q3: A patient has had recent mechanical heart
Q4: The nurse notes in the patient's medication
Q6: When administering heparin subcutaneously, the nurse will
Q7: A patient will be receiving a thrombolytic
Q8: A patient has been prescribed warfarin (Coumadin)
Q9: A patient is being discharged on anticoagulant
Q10: A patient has been instructed to take
Q11: A patient who has been anticoagulated with
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents